<?xml version="1.0" encoding="UTF-8"?>
<ref id="r31">
 <label>31</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Meijer</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Hungnes</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Schweiger</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Valette</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>van der Werf</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
   <collab>Virology Task Groups of the European Influenza Surveillance Scheme</collab>
  </person-group>
  <article-title>Programme of the Community Network of Reference Laboratories for Human Influenza to improve Influenza Surveillance in Europe.</article-title>
  <source>Vaccine</source>. 
  <year>2006</year>;
  <volume>24</volume>(
  <issue>44-46</issue>):
  <fpage>6717</fpage>-
  <lpage>23</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2006.05.068</pub-id>
  <?supplied-pmid 16782242?>
  <pub-id pub-id-type="pmid">16782242</pub-id>
 </mixed-citation>
</ref>
